Rambam AG is a Swiss-based venture studio and accelerator platform for breakthrough drug discovery and development. Our portfolio of companies and programs is supported by a core group of seasoned industrial experts, PMs and dedicated functional experts from Switzerland, Portugal, Germany and the US.
Products, services, technology
Rambam Expert Systems Platform: AI-based platform for execution of discovery projects with the focus on small molecules - full responsibility for major project risks (timelines, budget, quality). Computational chemistry models, chem-bio suite, SAR fingerprinting, Mgmt of academic and CRO partners.
We partner with US and European venture companies on funding and utilize our Expert Systems’ technology platform for rational program design and execution to translate scientific insights into novel medicines.Our success- 20 programs and companies co-funded with OrbiMed, BGV and other partners.
Accelerator platform for breakthrough drug discovery and development, rational program design and execution to translate scientific insights into novel medicines. Rambam funded multiple success stories stemming from over 20 programs and companies co-funded with OrbiMed, BGV and other partners.
Be open for collaboration with US based venture fund, aimed to bring funding in the EU to co- invest in development programs. We have 20 US programs success track record, years of experience in product development and execution and knowhow in co - funding partnerships that help investment de-risking
We are looking for VC partners for co-investment in novel / best in class therapeutic targets in Immunology, Oncology, CNS and Infectious Diseases for small molecule drug modalities. We also are interested for collaboration with family office's and Venture Funds Pharma and Biotech.